lower price 98% Off-white or light yellow crystalline powder DROPERIDOL
548-73-2
Yes
2026-10-23
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Product Description
-
Seller Information
-
DescriptionKeywords
DROPERIDOL
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone;1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-2h-benzimidazol-2-on;1-(1-(4-(p-fluorophenyl)-4-oxobutyl)-1,2
DROPERIDOL;1-(1-[4-FLUOROBENZOYLPROPYL]-1,2,3,6-TETRAHYDRO-4-PYRIDYL)-2-BENZIMIDAZOLINONE;1-[1-(P-FLUOROBENZOYLPROPYL)-1,2,3,6-TETRAHYDRO-4-PYRIDYL]-2-BENZIMIDAZOLINONE;1-(1-(3-(p-fluorobenzoyl)propyl
Quick DetailsProName:lower price 98% Off-white or light yellow crystalline powder DROPERIDOL
CasNo:548-73-2
Molecular Formula:C22H22FN3O2
Appearance:Off-white or light yellow crystalline powder
DeliveryTime:Prompt shipment
PackAge:25kg/drum
Port:Hangzhou or Shanghai,China
ProductionCapacity:Metric Ton/Day
Purity:98%min
Storage:cool and dry
Transportation:BY SEA,AIR OR EXPRESS(TNT,DHL,FEDEX OR EMS)
LimitNum:1 Kilogram
Superiority
Appearance：
Off-white or light yellow crystalline powder
Identification ：
Conforms
Related substances：
Single impurity
≤
1.0%
Total impurity
≤
2.0%
Loss on drying
Residue on ignition：
≤
0.2%
Details
Appearance：
Off-white or light yellow crystalline powder
Identification ：
Conforms
Related substances：
Single impurity
≤
1.0%
Total impurity
≤
2.0%
Loss on drying
Residue on ignition：
≤
0.2%
ECHEMI Editorial ReferenceDroperidol is a Dopamine-2 Receptor Antagonist. Target: D2DRDroperidol is a butyrophenone, with anti-emetic, sedative and anti-anxiety properties.
Solid
Droperidol is an organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It has a role as an antiemetic, a dopaminergic antagonist, a first generation antipsychotic and an anaesthesia adjuvant. It is a member of benzimidazoles, an organofluorine compound and an aromatic ketone.|Innovar is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.|A butyrophenone with general properties similar to those of haloperidol. It is used in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)|Droperidol is a Dopamine-2 Receptor Antagonist. The mechanism of action of droperidol is as a Dopamine D2 Antagonist.|Droperidol is a butyrophenone with anti-emetic, sedative and anti-anxiety properties. Although the exact mechanism through which droperidol exerts its effects is unknown, droperidol may block dopamine receptors in the chemoreceptor trigger zone (CTZ), which may lead to its anti-emetic effect. This agent may also bind to postsynaptic gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS), which increases the inhibitory effect of GABA and leads to sedative and anti-anxiety activities.|A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)Basic Info-
Product Name:
Droperidol
Other Name:2H-Benzimidazol-2-one,1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-;2-Benzimidazolinone,1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-;1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2H-benzimidazol-2-one;McN-JR 4749;R 4749;Dehydrobenzperidol;Droperidol;1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone;1-(1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone;Inapsine;Droleptan;Inapsin;Dridol;Inopsin;Sintodril;Neurolidol;NSC 169874;1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl]-2,3-dihydro-1H-1,3-benzodiazol-2-one
CAS No.:548-73-2
Molecular Formula:C22H22FN3O2
InChIKeys:InChIKey=RMEDXOLNCUSCGS-UHFFFAOYSA-N
Molecular Weight:379.43
Exact Mass:379.43
EC Number:208-957-8
UNII:O9U0F09D5X
DEA Code Number:9801
NSC Number:757819|169874
DSSTox ID:DTXSID6022973
NCI Thesaurus Code:C458
Color/Form:White to light tan, amorphous or microcrystalline powder
ATC Code:N05AD08|N - Nervous system
HScode:2933995800
Categories:
Characteristics-
PSA:
52.6
XLogP3:3.5
Appearance:Solid
Density:1.3±0.1 g/cm3
Melting Point:145-146 °C
Flash Point:326.6±34.3 °C
Refractive Index:1.636
Water Solubility:4.1mg/L(30 ºC)
Storage Conditions:2-8°C
Vapor Pressure:2.02X10-11 mm Hg at 25 deg C (est)
Toxicity:LD50 oral in rat: 750mg/kg
Odor:Odorless
Taste:Tasteless (no taste test is recommended)
PKA:7.46None
Henrys Law Constant:Henry's Law constant = 2.66X10-15 atm-cu m/mol at 25 °C (est)
Dissociation Constants:7.46|pKa = 7.6
Collision Cross Section:195 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|197.7 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated]
Experimental Properties:Hygroscopic|Crystals, mp 145-146.5 °C; UV max (9:1, 0.1 M HCl:methanol): 245, 280 nm (E = 15600, 7500) ... pKa = 7.64. Solubility at 25 °C (g/100 mL): chloroform 40; DMF 17; benzene 0.55; methanol 0.41; ethanol 0.34; ether 0.24; 0.1 M HCl 0.15; water <0.001 /Droperidol hydrate/
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Commercially available droperidol injection should be protected from light and stored at room temperature (15-25 deg C).
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
-
Location:
1613 Guangyin Building,No.42 E.Fengqi Road,Hangzhou,310012 China.
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
7 days
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
11-50
-
Year of Establishment:
2011
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
